Trademarkia Logo

Canada

C$
Trademark Search in Canada
MODERNA & DESIGN

View On IC.GC.CA

MODERNA & DESIGN
REGISTERED

on 2 Jun 2020

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

MODERNATX INC.

325 Binney StreetCambridge, MA 02142

US

Serial Number

1870823 filed on 1st Dec 2017

Registration Number

TMA1079224 registered on 2th Jun 2020

Registration expiry Date

2th Jun 2030

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

MODERNA & DESIGN

Trademark usage description

polypeptide encoding nucleic acids for scientific research medical, biological and pharmaceutical preparations containing the polypeptide encoding nu Read More

Vienna Information

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 11 . 11

Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information

Class [001]
Polypeptide encoding nucleic acids for scientific research

Classification kind code

11

Class [005]
Medical, biological and pharmaceutical preparations containing the polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, namely, Cystic fibrosis, Methylmalonic acidemia, Propionic acidemia, Phenylketonuria, Ornithine transcarbamylase deficiency, Maple syrup urine disease, Arginase-1 deficiency, Factor VIII deficiency, Glycogen storage disorder type 1a, Adult-onset type II citrullinemia, Progressive familial intrahepatic cholestasis type, cancers, neurological disorders, namely, Alzheimer's disease, Multiple sclerosis, Amyotrophic Lateral Sclerosis, ataxia, brain injury, pain, motor neuron disease, spinal cord injury, Parkinson's disease, stroke, epilepsy, neuropathy, cardiovascular disorders, inflammatory disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory pelvic diseases, immunoregulatory disorders, namely, autoimmune diseases, immunologic deficiency syndromes, metabolic disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy and anemia, infectious disorders, namely, viral infections, Respiratory Syncytial Virus, Cytomegalovirus, Human metapneumovirus, Human parainfluenza virus type 3, Varicella zoster virus, Influenza virus, Zika virus, Chikungunya, respiratory infections, eye infections, CNS infections, urinary tract infections and reproductive disorders, namely, urological diseases, infertility and sexually transmitted diseases.

Classification kind code

11

Class [042]
Design, engineering, research, development and testing services in the field of polypeptide encoding nucleic acids

Classification kind code

11

Mark Details

Serial Number

1870823

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 16th Oct 2019		Advertised
Submitted for opposition 26
on 25th Sept 2019		Approved
Submitted for opposition 27
on 25th Sept 2019		Approval Notice Sent
Submitted for opposition 15
on 17th Jun 2019		Correspondence Created
Submitted for opposition 135
on 16th Apr 2019		Amendment to Application
Submitted for opposition 22
on 29th Jan 2019		Search Recorded
Submitted for opposition 20
on 29th Jan 2019		Examiner's First Report
Submitted for opposition 31
on 4th Dec 2017		Formalized
Submitted for opposition 30
on 1st Dec 2017		Filed
Submitted for opposition 1
on 1st Dec 2017		Created